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Abstract
Embryologic and genetic evidence suggest a common origin of haematopoietic and endothelial lineages. In the murine
embryo, recent studies indicate the presence of haemogenic endothelium and of a common haemato-endothelial
precursor, the haemangioblast. Conversely, so far, little evidence supports the presence of haemogenic endothelium and
haemangioblasts in later stages of development. Our studies indicate that human cord blood haematopoietic progenitors
(CD34+45+1442), triggered by murine hepatocyte conditioned medium, differentiate into adherent proliferating
endothelial precursors (CD144+CD105+CD146+CD31+CD452) capable of functioning as haemogenic endothelium. These
cells, proven to give rise to functional vasculature in vivo, if further instructed by haematopoietic growth factors, first switch
to transitional CD144+45+ cells and then to haematopoietic cells. These results highlight the plasticity of haemato-
endhothelial precursors in human post-natal life. Furthermore, these studies may provide highly enriched populations of
human post-fetal haemogenic endothelium, paving the way for innovative projects at a basic and possibly clinical level.
Citation: Pelosi E, Castelli G, Martin-Padura I, Bordoni V, Santoro S, et al. (2012) Human Haemato-Endothelial Precursors: Cord Blood CD34+ Cells Produce
Haemogenic Endothelium. PLoS ONE 7(12): e51109. doi:10.1371/journal.pone.0051109
Editor: Antonio Paolo Beltrami, University of Udine, Italy
Received June 28, 2012; Accepted October 29, 2012; Published December 4, 2012
Copyright:  2012 Pelosi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Ministero della Salute (The Italian Ministry of Health), Rome, Italy (RF2006-411189); Associazione Italiana per la Ricerca sul Cancro (AIRC) (The Italian
Association for Cancer Research), Milan, Italy; MIUR, Ministero Universita` e Ricerca Scientifica (The Ministry of Education, University and Research), Tavola Valdese
OPM., Regione Lazio Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: elvira.pelosi@iss.it(EP); tripodi@bce.uniroma1.it(MT)
Introduction
The origin(s) of vascular and blood cell types during develop-
ment is not entirely clear and may be different depending on the
stage of hematopoiesis and the site of blood cell development.
During primitive hematopoiesis, the earliest stage of blood
development, hematopoietic and endothelial cells emerge simul-
taneously. Their origin is highly debated: if, as it has been
proposed, they are issued independent of the differentiation of
mesodermal stem/progenitor cells [1] or, according to an
alternative view, they derive from a common bi-potent progenitor
called the hemangioblast [2,3]. Evidence supporting the transient
existence of the haemangioblast was first provided by in vitro
differentiation of embryonic stem cells [4]; haemangioblasts have
also been isolated in the avian caudal mesoderm [5], as well as in
mouse [2] and zebrafish [6] embryos, and human cord blood (CB)
CD34+ cells, specifically in the CD34+KDR+ subpopulation [7]
and CD34+133+ subpopulation [8].
Primitive hematopoietic activity is eventually supplanted by the
second wave of multilineage (definitive) hematopoiesis. Pluripotent
hematopoietic stem cells (HSCs) and multipotent hematopoietic
progenitor cells (HPCs) are considered to be issued from
specialized endothelial cells, commonly defined as haemogenic
endothelium. While the existence of hemangioblastic cells in vivo,
as well as their contribution to the development of primitive
hematopoiesis remains controversial, growing evidence supports
the concept that multipotent HSCs and multilineage HPCs arise
from haemogenic endothelium (for review: [9]). Embryos of many
vertebrates show transient haemogenesis on the aortic endotheli-
um floor, designated as haemogenic endothelium [10,11]. The
haemogenic endothelium model is further supported by studies
showing that HPCs of both embryonic and yolk sac origin
differentiate from VE-cadherin+ ECs. [12,13,14] Similarly, HSC
and HPCs are generated in the placental vasculature, apparently
through haemogenic differentiation of placental endothelium. [15]
Elegant experiments based on VE-cadherin lineage tracing and
single-cell imaging provide definitive evidence for the endothelial
origin of haematopoietic cells in ES culture [16], as well as in
zebrafish [17,18] and mouse [19] embryos. Notably, other studies
suggested that the haemangioblast generates haematopoietic cells
through a haemogenic endothelium intermediate stage [20].
However, is currently unknown whether haemogenic endothe-
lium contribute to the development of hematopoiesis, also at later
stages of development (i.e. whether haemogenic endothelium exist
in human cord blood and bone marrow). Some observations
suggest a possible contribution of haemogenic endothelium to the
generation of HSCs during adult life. In fact, Zovein et al. [11]
through embryonic lineage-tracing studies, which label haemo-
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genic endothelium before definitive hematopoiesis and follow their
progeny HSCs during adult life, demonstrate that although
embryonic HSCs remain functional in the adult, they do not
account for all hematopoietic cells generated postnatally. Further-
more, Wu et al. [8] provided preliminary evidence that human
CD34+ cord blood cells, when grown in appropriate cell culture
conditions, could generate an endothelial cell progeny endowed
with properties of haemogenic endothelium.
We previously described [21] the influence of soluble factors in
conditioned medium released by murine hepatocyte conditioned
medium (MH-CM) on human CB CD34+ progenitors; in long-
term MH-CM culture we obtained growth of: (i) a bulk CD34+
population differentiating toward the endothelial lineage and (ii)
single CD34+ cells expressing both haematopoietic (CD45) and
endothelial (CD144) markers.
In the present study, we explored the potential of human CB
CD34+ HPCs to differentiate into haemogenic endothelium. In
long-term culture, the addition of MH-CM stimulates the initial
CD34+45+1442 HPCs to generate adherent CD452144+
endothelial precursors capable of self-renewal/proliferation and
to differentiate in endothelial cells in vivo. These cells, instructed by
haematopoietic growth factors (HGFs), rapidly differentiate into
CD45+144+ cells that in turn generate either (i) CD45+
haematopoietic cells (mainly of erythroid and megakaryocytic
type) when grown in haematopoietic medium, or (ii) CD144+ ECs
if cultured in endothelial medium.
Figure 1. Characterization of CB CD34+ cells grown in MH-CM culture. A- Growth curve of cells grown in MH-CM; a representative
experiment out of 10 is shown. B- Percentage of adherent and non-adherent cells grown in MH-CM at day 30; a representative experiment out of 10 is
shown. C- Phase-contrast morphology of day 30, adherent and non-adherent cells (original magnification 10x). Non-adherent cells are round and
more refractive, while adherent cells are flat and less refractive; a representative experiment out of 10 is shown.
doi:10.1371/journal.pone.0051109.g001
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Results
Cord Blood CD34+ Cell Cultures in MH-CM Medium Allow
for the Appearance of Endothelial Progenitors
We previously described the influence of MH-CM on CB
derived CD34+45+1442HPCs. Specifically, MH-CM allowed for
long-term culture of proliferating CD34+ cells, which gradually
gave rise to two different populations: i) one floating and round
shaped, composed of CD45+ haematopoietic cells and ii) one
firmly attached to the wells, which acquired endothelial morphol-
ogy and became CD144+ [21]. Figure 1 recapitulates these results
showing the expansion of the CB CD34+ cell derived progeny
cultured in MH-CM up to 60 days, and the cellular morphology
at day 30, when the floating and adherent cell subpopulations are
clearly distinguishable.
From these observations, we further characterized the CD34+
derived adherent cells fraction at both phenotypic and functional
levels.
Firstly, CD34+ derived adherent cell progeny, cultured in MH-
CM for 30 days and isolated by washing away the floating cells,
was phenotypically characterized using a broad range of different
cell-surface markers. As shown in Figure 2A the majority of cells
were positive for: CD144, CD146, CD147, CD105 (endothelial
markers), CD34 (haemato-endothelial marker), CD29, CD44
(mesenchymal markers) CD61, i.e. b3 integrin-GPIIIa (megakar-
yocytic-endothelial-osteoclastic marker) and CD13, i.e. aminopep-
tidase N (myeloid-endothelial marker). On the contrary, these cells
were found largely negative for other haematopoietic markers,
including CD45, Glycophorin-A (GPA, erythroid marker), CD15
(myeloid marker) CD41 and TPO-R (megakaryocytic markers).
Since, no univocal endothelial markers have been identified [22]
to date, the endothelial nature of the adherent cells was better
characterized by multiple markers analysis: the expression of
CD45 and CD144 was analyzed in combination with other
endothelial markers (i.e. CD146, CD105, CD31, CD54 and Tie2).
This characterization by triple labeling demonstrated that the
great majority of the CD452CD144+ adherent population co-
expresses all of these markers (Fig. 2B). Notably, these results were
confirmed by confocal analysis of the adherent cell population. As
shown in Figure 2C, the adherent cells co-express endothelial
antigens, while they are negative for CD45. Altogether this
immunophenotypic analysis supports the endothelial nature of the
CD34+ derived adherent cells.
Next, we aimed to characterize the adherent population at
functional and transcriptional levels. The day-30 adherent
subpopulation, when seeded in endothelial clonogenic conditions,
was found to give rise to endothelial colonies, (efficiency ,60%)
(Figure 3A). Their further characterization in vitro and in vivo
demonstrated that when cultured on matrigel these cells form
tubuli (Figure 3B), the in vivo experiments most notably demon-
strated their nature of endothelial progenitors. In fact, Figures 3D
and 3E show the capacity of these cells to incorporate into
functional, blood -containing, newly forming vasculature, and
sustain tumor growth in vivo.
Transcriptional analysis illustrates how these cells express a
coherent and broad repertoire of endothelial genes. Moreover,
their further growth in endothelial medium (EGM2) resulted in
long-term proliferation with a gene expression profile further
supporting their endothelial nature (3F and 3G).
Overall, the adherent population, arising from the long term
CD34+ culture in MH-CM, generates a cell population with a
defined immunophenotypic, transcriptional profile, and that
possesses the functional characteristics of endothelial precursors.
The CD34+ Derived EPCs, Instructed by HGFs,
Differentiate into CD144+45+ Cells and, Eventually, into
Haematopoietic Cells
Since, as reported above, the appearance of the adherent
endothelial precursor population in long-term MH-CM cultures of
CD34+ cells is associated with the presence of non- adherent
hemopoietic cells, we hypothesized that the adherent cells may
contribute not only to the long- term maintenance of haemato-
poietic precursors but also to its generation. We reasoned that
instructive signals mediated by specific cytokines may unveil a
haematopoietic potential of the endothelial precursor population.
To challenge this hypothesis, the adherent cells, generated for
30 days in MH-CM culture, were seeded into multilineage
haematopoietic medium in long-term experiments. Notably, the
adherent cells gave rise to a population of erythro-megakaryocytic
cells seemingly generated by CD144+ EPCs. Specifically, we
observed the appearance of erythroid cells (peaking at day 10–20
of culture in haematopoietic medium) and subsequently of
megakaryocytic elements (peaking at day 30–40), as revealed by
immunophenotypic (Figure 4A, left panel) and morphological
(Figure 4B) analysis; the CD14+CD15+ granulo-monocytic cells
only represent a minority of the generated progeny. Notably, this
dramatic phenotype switch is associated with significant cell
expansion (Figure 4A, right panel). Similar results were obtained
using adherent cells obtained after 60 days in MH-CM culture (not
shown).
These data suggest that in MH-CM culture, the adherent EPC
population has the capacity to differentiate toward haemopoietic
lineages, particularly the erythro-megakaryocytic ones: this may
imply that these cells are reminiscent of embryonic cells previously
described as haemogenic endothelium.
To further investigate the suggested differentiation capacity of
the adherent EPCs toward haematopoiesis (see above), we studied
the changes occurring in these cells after culture in haematopoietic
medium in short-term experiments. Specifically, we first
monitored the adherent cells for the expression of endothelial-
specific (CD144) and haematopoietic-specific (CD45) markers
throughout the initial 12 days of culture in haematopoietic
medium. The results showed that the haematopoietic medium
rapidly induces the conversion of the CD144+ cell population into
CD45+ haematopoietic cells (Figure 4C). In fact, the majority of
adherent cells, initially CD144+452, became CD144+45+ within
,5 days in haematopoietic medium culture. Subsequently, the
CD144+45+ cell population rapidly declined and it was replaced
by ,80% CD144245+ cells, within ,7 days of culture.
Overall, the EPCs, instructed by the haematopoietic medium,
are replaced within a few days by haematopoietic cells: notably
this happens through an intermediate stage of cell population
Figure 2. Phenotypic characterization of adherent cells in MH-CM culture. A- Immunophenotypic characterization of adherent cells
generated by CD34+ cells cultured in MH-CM for 30 days. Mean values +/2 SD of 15 independent experiments are shown. B- Flow cytometry analysis
of the indicated endothelial markers expressed by adherent cells generated by CD34+ cells cultured in MH-CM for 30 days. Cells have been labelled
with CD45, CD144 and with the indicated antigen. Shown are plots of CD45 negative cells (87+/29%). The percentage of double-positive cells for the
two endothelial antigens are given. A representative experiment out of 15 is shown. C- Confocal imaging: triple immunostaining analysis for the
indicated antigens of adherent cells generated by CD34+ cultured in MH-CM for 30 days. A representative experiment out out of 5 is shown.
doi:10.1371/journal.pone.0051109.g002
Cord Blood Derived Haemogenic Endothelium
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e51109
Figure 3. Functional characterization of adherent cells in MH-CM culture. A- left panel -Clonogenetic assay of adherent cells generated by
CD34+ cultured in MH-CM for 30 days, carried out in semi-solid culture supplemented with the indicated medium. Right panel - Light microscopy
image of a single cell-derived colony grown in semi-solid EGM2 endothelial medium. A representative experiment out of 5 is shown. B-Phase-contrast
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expressing both haematopoietic and endothelial markers. To
formally exclude that our observation derived from expansion of a
contaminant hemopoietic subpopulation, we sorted the adherent
cells (day 30 of MH-CM culture) by means of CD144 and CD45
markers. Specifically, CD144+452 were sorted using a gate
ensuring .99% cell purity (Figure 5A). Purified CD144+452
cells, grown in haematopoietic medium, were analyzed by FACS
and confocal analysis for expression of CD144 and CD45 markers
(Figure 5B) at different time points, thus monitoring their
phenotypic conversion. At a later time (around 12 days of culture
in haematopoietic medium) all cells were CD144245+ that
generated first an erythroid and then a megakaryocytic progeny
(Figure 5C), as assessed by morphological characterization and
immunophenotypic analysis for GPA and CD41 expression
(erythroid and megakaryocytic markers, respectively). Taken
together, our data indicate that the adherent CD144+452 EPCs
function as haemogenic endothelium capable of generating
differentiated CD45+ haematopoietic progeny, mostly megakar-
yocytic and erythroid, through an intermediate transient
CD144+45+ developmental stage.
Finally, we aimed at proving the observed capacity of the
adherent CD144+452 to give rise, when instructed by HGFs, to
haematopoietic cells at a single cell level. Specifically, we
performed a series of limiting dilution of the CD144+45+ cells
isolated from the adherent cells endowed by haemogenic
endothelium capacity. As control, similar experiments were also
performed in parallel on the HGFs-uninstructed cell population
(CD144+CD452). To ensure cell clonality, sorted cells were
diluted down to 0.25 cell/well: after their seeding in culture, the
wells were inspected by appropriate microscopy examination to
ensure that ,75% of the wells were cell-negative while the ,25%
of positive wells contained a single cell (see Materials and
Methods). Single sorted cells were followed by cellular/molecular
analysis of their progeny. Unicellular cultures of CD144+45+ cells,
within three weeks of culture generated the following colonies:
40% generated colonies displaying a mixed haemato-endothelial
phenotype when seeded in MH-CM, 41% produced haematopoi-
etic colonies in the haematopoietic medium and 35% produced
endothelial colonies in the endothelial medium. Differently,
unicellular cultures of CD144+CD452 cells, gave rise to 33%
endothelial colonies (in endothelial medium) but to only a very
small number of hematoendothelial colonies (in MH-CM) and
hematopoietic colonies (in hemopoietic medium): 4% and 2%
respectively (Fig. 6B).
The clonal progenies were also analyzed by combined CD144/
CD45 confocal microscopy: cells derived from colonies grown in
hematopoietic medium were found CD144 negative and CD45
positive (Figure 6B).
Altogether, these results, summarized in figure 6A, indicate that
human CB derived CD34+ cells, instructed by MH-CM to
proliferate and acquire the EPC phenotype, function as haemo-
genic endothelium: they may be reprogrammed by HGFs into the
haemopoietic lineages, the latter ones being largely composed of
erythroid and megakaryocytic cells.
Discussion
Recent studies on murine embryos provide evidence that
haemangioblasts generate haematopoietic cells/endothelial cells
through the haemogenic endothelium [20,22,23]. Little is known
of the plasticity of endothelial/haematopoietic precursors at later
stages of development. Human CB CD34+ cells provide a unique
model to investigate the common origin of haematopoietic and
endothelial lineages in perinatal life. In fact, these cells represent a
standard source for 90295% HPCs, as well as for a minority of
EPCs [24,25] and early progenitor cells that can be programmed
to efficiently generate induced pluripotent stem cells [26]. Building
upon our previous work [7], the present studies show that the CB
CD34+ cells may be instructed to generate haemogenic endothe-
lium, which in turn, when properly instructed, differentiates into
CD45+ CD144+ cells able to differentiate into hemopoietic cells;
particularly, we described this multi-step differentiation process at
morphological, immunophenotypical and functional levels. Par-
ticular attention was devoted to the controls ensuring clonality in
the limiting dilution unicellular culture, as detailed above.
Initially, the CB CD34+cells, instructed by MH-CM, acquire an
adherent phenotype as well as EPC functional properties. These
cells were characterized as CD144+, CD105+, CD146+, CD54+,
CD31+, Tie2+, CD49d-, CD432, CD1332 and proven to
generate functional vessels in vivo. This specific EPC cellular
population shows remarkable plasticity, specifically the capacity to
express the haematopoietic gene differentiation program upon
appropriate instruction. In fact these EPCs, triggered by a HGF
cocktail, switch in ,1-wk into a CD144+45+ progeny, comprising
of ,30–40% functional progenitors capable of giving rise
haematopoietic populations. Live imaging of the switch from
CD144+CD452 to CD144+CD45+ cells, demonstrated, in line
with a previous observation [16], that this transition is not
mechanistically linked to mitosis. The frequency of cells capable of
haemogenic transition in this cell population is dramatically more
elevated than that previously reported by experiments on
embryonic stem cells [16,27], and studies on CB CD34+ cells
[7,8].
After a longer period of time, the HGF cocktail instructs the
intermediate, transient CD144+CD45+ cell population to gener-
ate a haematopoietic progeny, largely composed of both erythroid
morphology of adherent cells cultured on matrigel supplemented with EGM-2 for 12 hours (original magnification 10x). A representative experiment
out of 5 is shown. C- Immunohistochemistry evaluation of adherent cells, generated by CD34+ cultured in MH-CM for 30 days, engrafted in breast
cancer-bearing NSG mice (n = 5). Human CD34 (i,ii,iii) and human CD31 (iv) detect functional vessels containing red blood cells. These antibodies are
human-specific and do not cross react with mouse vessels (vi). A representative experiment out of 5 is shown. (v) Tumor volume quantification
showing that the volumes of tumors where breast cancer cells were co-injected with the adherent cells generated by CD34+ cells are significantly
higher (* p,0.04) than the volume of tumors where breast cancer cells alone were injected in NSG mice (n = 5/group). D-Confocal laser-scanning of
human CD34 antigen distribution in a tumor section of a MB-MDA436 plus adherent cells, generated by CD34+ cultured in MH-CM for 30 days.
Images were acquired using a Leica TCS SP5 confocal microscope and sequential Z-stacks were performed using a 6361.4NA oil immersion objective,
zoom 3X, 0.3 mm z step. Snapshot images are orthogonal sections of the z-stacks taken at points along the vessel’s cavity. A representative picture of
one tumor out of 5 is shown. E- Expression levels of haemopoietic and endothelial marker genes obtained from microarray analysis of fresh CB CD34+
cells (CD34), the adherent cellular progeny obtained after 53 days of culture in MH-CM (Adherent Cells in MH-CM) and this adherent cellular progeny
grown in endothelial medium (EGM2) for additional 7 days (Adherent Cells in Endot. Medium). Expression values were normalized using CD34+ cells
as control. A global up-regulation of endothelial marker genes was observed in adherent cells grown in MH-CM, both prior to and after instruction by
EGM2, whereas haemopoietic markers were either unvaried or down-regulated. A representative analysis out of 3 is shown. F- Growth curve of the
adherent cellular progeny obtained from CB CD34+ cells grown in MH-CM when transferred into EGM2 endothelial medium. A representative
experiment out of 10 is shown.
doi:10.1371/journal.pone.0051109.g003
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and megakaryocytic cells, thus reproducing the haematopoietic
cell expression pattern observed in early human development.
Notably the CD144+CD45+ haematopoietic progeny display a
number of features commonly observed in hemopoietic cells
derived from CD34+ cells isolated from cord blood. In particular,
erythroid cells express fetal hemoglobin and megakaryocytic cells
are mononucleated or scarcely polyploidy [28].
These results raise a number of questions, while offering new
and interesting opportunities. Indeed, future studies will be
necessary to define the in vivo significance of the present
observations, specifically of haemogenic endothelium in both
postnatal and adult human life. In murine and zebrafish embryo,
direct generation of haematopoietic precursors from aortic
haemogenic endothelium has been demonstrated [17,18,19].
However, other studies also suggest the generation of haemato-
poietic cells from haemangioblasts in the mesenchymal tissue
(reviewed in [29]), or from haemogenic endothelium through
haemangioblasts [20].
In our in vitro studies on CB human HPCs/EPCs, we described
the slow conversion of the CB CD34+ HPC population into
haemogenic endothelium, induced by the MH-CM instruction.
MH-CM was previously characterized for its capacity to sustain
murine and human early progenitor differentiation [21,30,31].
While the biological role of specific GFs/GF cocktails present in
MH-CM has not yet been elucidated, we provided evidence that
CD34+ proliferation and differentiation in endothelial precursors
bearing haemogenic potential also require CD34+ cells to release
autocrine/paracrine soluble factors [21]. As described, the
haemogenic endothelium/haematopoietic interconnection was
mechanistically controlled by a multilineage HGF cocktail that
rapidly reprograms haemogenic endothelium, first into haemato-
poietic progenitors, and then into erytrocytic/megakaryocytic
cells.
The phenomena described here, together with the embryonic
studies mentioned above, highlight the exquisite plasticity of
haematopoietic and endothelial primitive cells for interconversion
and differentiation, possibly driven in vivo by the microenviron-
ment and reproduced in vitro through specific GF/cytokine stimuli.
While studies on murine embryos suggest that haemogenic
endothelium is a transient population linked to specific develop-
mental stages, our data indicate that haemogenic endothelium is
not characterized by its transient and exclusive existence in the
embryonic period, but rather suggest its existence and, possibly, its
functional role throughout human life.
In our view, availability of a purified population of haemogenic
endothelium will allow innovative studies at a basic and possibly
clinical level. At the clinical level, strategies might be devised to
expand the purified haemogenic endothelium in vitro in order to
explore its potential therapeutic use.
Materials and Methods
Cell Purification
Cord blood was obtained from healthy, full-term placentas
according to institutional guidelines A.Fa.R. Research Centre, San
Pietro Hospital, Fatebenefratelli, Rome, 00100, Italy. The use of
human cord blood samples for research pourposes was approved
by the Institutional Review Board of the Istituto Superiore di
Sanita`, Rome, Italy. Low-density mononuclear cells (MNCs) were
isolated and CD34+ cells purified as in [7]. The purity of CD34+
cells assessed by flow cytometry was routinely .95%. Each single
experiment may included pooled cells derived from different (2/3)
cords blood. In some experiments CD144+452 cells were sorted
twice to ensure a final purity of .99%, using a fluorescence-
activated cell sorter, FACSVantage or FACSAria (Becton-Dick-
inson).
Cell Culture
Liquid culture. Haemato-endothelial culture. Isolated
CD34+ cells were cultivated in MH-CM [21] either in bulk
culture (density 1,2–1,56105 cells/cm2) on collagen-coated 24–
12–6 well plates or in single cell culture (by limiting dilution, see
[7]) in flat 96 well plates. Half MH-CM was replaced with fresh
conditioned medium twice a week.
Haematopoietic multilineage culture. (see [7]) involved
serum-free medium (IMDM, GIBCO) containing delipidated
bovine serum albumin (BSA 10 mg/ml), saturated human
transferrin (Tf 700 mg/ml), and human low-density lipoprotein
(LDL 40 mg/ml), supplemented with a haematopoietic growth
factor (HGF) cocktail: flt3 ligand (FLT3) 100 ng/ml, kit ligand
(KL) 100 ng/ml, IL-3 10 ng/ml, GM-CSF 10 ng/ml, Tpo
100 ng/ml, Epo 3 U/ml, G-CSF 500 U/ml, M-CSF 250 U/ml,
IL-6 10 ng/ml and bFGF 10 ng/ml. (in some experiments VEGF
100 ng/ml was also added to support EC survival/growth) in a
fully humidified 5% CO2 5% O2 atmosphere. FLT3, KL, Tpo,
G-CSF and bFGF were purchased from PeproTech EC; IL-3,
GM-CSF, Epo, M-CSF, IL-6 were provided by R&D System.
Endothelial culture. Was performed on collagen-coated
wells in standard EGM2 medium (CAMBREX).
Clonogenic Culture
Clonogenic assays in both bulk and limiting dilution culture
were essentially performed as in [7].
Bulk culture. Briefly, the adherent and non-adherent cells
were plated (1.0 22.06104 viable cells/ml) in duplicate dishes in
haematopoietic culture in serum-free medium supplemented with
methylcellulose (Methocult H 4100 Stem cell Technologies,
Vancouver BC, CA) containing the multilineage HGF cocktail,
BSA, saturated human Tf, and human LDL. The colonies were
scored at day 15–20. Endothelial culture was performed in EGM2
Figure 4. Immunophenotypic and morphological analysis of adherent ECs progeny following transfer into haematopoietic culture.
A- Left: Time course FACS analysis of adherent cells generated by CD34+ cells cultured in MH-CM and then transferred, at day 30, to haematopoietic
medium and characterized for lineage -specific antigen expression. A representative experiment out of 5 is shown. - Right: Growth curve of erythroid
(E) and megakaryocytic (Mk) cells generated from the culture of day- 30 adherent cells in haematopoietic medium. A representative experiment out
of 5 is shown. B- Morphological analysis of adherent cells generated by CD34+ cells cultured in MH-CM for 30 days, then transferred to
haematopoietic medium and grown for additional days (day 30= day 0 in haematopoietic medium, day 40 = day 10 in haematopoietic medium, day
50 =day 20 in haematopoietic medium, day 60= day 30 in haematopoietic medium). At day 40, the large majority of cells had a morphology typical
of the erythroid lineage elements at various stages of maturation. At later days of culture (day 50 and 60), erythroid cells were replaced by a cell
population with a morphology compatible with the cord blood derived megakaryocytes (i.e. showing limited capacity of polyploidization). Pictures of
a representative experiment out of 3 are shown. C- CD144 and CD45 expression analysis of adherent cells generated by CD34+ cells cultured in MH-
CM for 30 days, then transferred to haematopoietic medium (i.e. day 33= day 3 in haematopoietic medium, day 36 =day 6 in haematopoietic
medium and so on). The percentage of CD144+452, CD144+45+ and CD144245+ cells from 8 independent experiments is reported (mean values
6SEM ).
doi:10.1371/journal.pone.0051109.g004
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medium and the colonies were scored at day 20–25. Haemato-
endothelial culture was carried out in MH-CM: the colonies were
scored at day 15–20 and the analysis and characterization of
colonies was performed as described. [7].
Limiting dilution unicellular culture. As reported [7], the
adherent and non-adherent cells were seeded in 96 flat wells at
limiting dilutions (down to 0.25 cell/well): the wells were collagen-
coated and contained either serum- free medium supplemented by
multilineage HGF cocktail, or the EGM2 medium or MH-CM
medium. 470 wells were utilized for each experiment. In
experiments involving a dilution of 0.25 cell/well, we verified
the presence of ,75% cell-negative wells and the presence of a
single cell in the ,25% positive wells: this analysis was based on
direct visual injection of the wells by means of an ad hoc designed
EVOS AMG microscope (18421 Bothell-Everett Hwy, Suite 150
Mill Creek, WA 98012), specifically designed for unequivocal
analysis of single cell culture wells. In fact, colonies were detected
only in some unicellular wells, but never observed in cell-negative
ones.
Figure 5. Immunophenotypic and morphological analysis of sorted CD144+452 following transfer into haematopoietic culture. A-
Left: Phase-contrast morphology of total adherent cell population generated by CD34+ cultured in MH-CM for 30 days., - Right: Plots of pre-sorting
and CD144+452 sorted population and morphology of post-sorted adherent CD144+452 cells at day 30 of culture. Cells were stained with MGG and
analyzed by standard microscopy (406magnification). A representative experiment out of 10 is shown. B- Top: Time course immunophenotypic
analysis of sorted CD144+452 cells for CD144 and CD45. Controls show autofluorescences at each day of analysis. - Bottom: Confocal double
immunofluorescence analysis for CD45 (green) and CD144 (red) antigen expression in CD144+/452 cells undergoing haemogenic differentiation at
the indicated days in haemopoietic medium. A representative experiment out of 10 is shown. C- Left: MGG staining and phase-contrast morphology
of sorted CD144+452 cells grown in haemopoietic medium for the indicated time. - Right: Immunophenotypic analysis for GPA and CD41 of sorted
CD144+452 cells grown in haemopoietic medium for 12 and 25 days (day 42= day 12 in haematopoietic medium, day 55= day 25 in haematopoietic
medium). A representative experiment out of 5 is shown.
doi:10.1371/journal.pone.0051109.g005
Figure 6. Differentiation of human post-natal haemogenic endotelium into haematopoietic cells. A- Schematic representation of the
various stages of haemogenic endothelium differentiation towards haemopoietic cells. B- Top Clonogenetic assay of sorted CD144+452 cell
populations in unicellular liquid culture in the presence of endothelial, MH-CM and haematopoietic medium. -Middle Clonogenetic assay of sorted
CD144+45+ cell populations in unicellular liquid culture in the presence of MH-CM and haematopoietic medium. Single cells (at a 0,25 cell/well
dilution) were seeded in the different media: the number and the morphology of colonies scored after 20 days. Three independent experiments are
reported. - Bottom: Confocal double immunofluorescence analysis for CD45 (green) and CD144 (red) antigen expression in endothelial, haemat.-
endot. and haematopoietic colonies grown in unicellular liquid culture in the presence of the different media described above.
doi:10.1371/journal.pone.0051109.g006
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Cell Analysis
Morphology. Cells were harvested at different days of
culture, smeared on slides by cytospin centrifugation, and stained
with May-Grunwald Giemsa. Cells were observed by conventional
light field microscopy.
Antibodies
The following monoclonal antibodies were used: fluoresceine
isothiocyanate (FITC) anti-CD15, anti-CD45, anti-CD56, anti-
CD144; allophycocyanine (APC) anti-CD45 and anti-CD117;
phycoerythrin (PE) anti-CD13, anti-CD14, anti-CD29, anti-
CD34, anti-CD41, anti-CD44, anti-CD45, anti-CD61, anti-
CD90, anti-CD105, anti-CD110 (TpoR), anti-CD146, anti-
CD147, anti-CD166, anti-CD235a (GPA), anti-HLA-ABC, anti-
HLA-DR and anti-GM-CSFRa (CD116) (all from BD Pharmin-
gen). Phycoerythrin anti-VEGF-R2 (KDR), anti-hEpoR, anti-
hACE (CD143), anti-CD144 (VE-Cadherin) and anti-Tie-2 (all
from R&D Systems).
Flow Cytometry
Cells were suspended in Ca++ Mg++-free phosphate-buffered
(PBS) containing 20% FCS, mouse IgG (40 ug/ml), incubated for
10 minutes on ice, and labelled with fluorochrome –conjugated
mAbs for 30 minutes on ice. Cell fluorescence was analyzed with
the FACS Canto (Becton Dickinson).
Immunofluorescence
Cells double-stained with PE anti-CD144 and with FITC anti-
CD45 conjugated antibodies, as described above, were fixed with
1% paraformaldehyde and rinsed with PBS, 1% BSA, and 0.1%
sodium azide. After washing, cells were rinsed with PBS and
spotted on lysine-treated glass slides, mounted on a glass coverslip
with SlowFade Gold antifade reagent with DAPI (Invitrogen) and
analyzed using a confocal microscope (Leica, Wetzlar, Germany).
Microarray Analysis
Biotin-labeled cRNA targets were obtained from 100 ng of each
RNA sample and hybridized to Human GENE ST 1.0 GeneChip
arrays according to Affymetrix standard protocols (Affymetrix,
Santa Clara, CA, USA). GeneChip.cel files were analyzed using
Partek Genomic Suite 6.4, and further elaborated with Gene-
Spring 7.0 (Agilent).
Capillary Tube Formation Assay
Capillary tube formation was assessed as described [32], seeding
2–104 ECs/well in Matrigel supplemented with the EGM-2
medium. After 12 hours, capillary-like formation was observed by
microscopy.
In Vivo Analysis
Mice and orthotopic mammary fat pad
implantation. Experiments involving animals were done in
the animal facilities at IFOM-IEO campus (Milan, Italy), in
accordance with the Italian Laws (D.L.vo 116/92 and following
additions), which enforces EU 86/609 Directive).
Accordingly to the regulatory requirements, our animal facility
is fully authorized by the Italian Ministry of Health (DM Nu 65/
2007-A) and our project has be notified to the Ministry of Health
with ID number 11/09. All surgery was performed under sodium
pentobarbital anesthesia, and all efforts were made to minimize
suffering. NOD.cg-PrkdcscidIl2rgtm1Wjll (NSG) were kindly
donated by Dr. L. Shultz, Female NOD.cg-PrkdcscidIl2rgtm1Wjll
(NSG) mice, 6- to 9-week-old, were bred and housed under
pathogen-free conditions in our animal facilities (IFOM-IEO
campus, Milan, Italy).
MDA-MB-436 triple negative breast cancer cells were pur-
chased from the American Type Culture Collection (ATCC,
Manassas, VA, USA) and cultured as suggested by the manufac-
turer. Prior to injection, tumor cells were trypsin detached, washed
twice and resuspended in PBS to a final concentration of 106 cells/
13 ml. Cell suspension was then mixed with 5 ml growth factor-
reduced Matrigel (BD Biocoat) and 2 ml trypan blue solution
(Sigma Aldrich) and maintained on ice until injection. In cases
where tumor cells were co-injected with 16106 endothelial cells,
cell suspensions were mixed before the final suspension in
Matrigel. Aseptic conditions under a laminar flow hood were
used throughout the surgical procedure. Mice (n.56group) were
anesthetized with 0.2% Avertin (Sigma Aldrich), made to lay on
their backs and 20 ml of cell suspension in Matrigel were injected
directly in the fourth mammary fat pad through the nipple using a
Hamilton syringe.
Tumor growth was monitored weekly using digital callipers and
tumor volume was calculated using the formula: L 6 W2/
2=mm3.
Immunohistochemistry
Immunostaining for anti-human-CD34 (clone BQEND/10,
Abcam), and anti-human-CD31 (clone JC70-A, Dako) was
performed on serial sections of formalin-fixed and paraffin
embedded biopsies with an automated immunostainer (Autostai-
ner, Dako, Glostrup, Denmark), using a commercial detection kit
(Dako EnVision Plus-HRP, Dako), according to the manufactur-
er’s instructions. Antigen retrieval was obtained by placing tissue
sections in 0.01 M EDTA buffer at pH 8.0 and underwent three
cycles at 90uC in a microwave oven operating at 780 W. Negative
control sections were incubated with non-immune mouse serum in
place of the specific primary antibodies and consistently lacked any
staining. Myeloperoxidases cytochemical staining in blood smears
was performed with a commercial kit (Sigma Aldrich) following
the manufacturer’s instructions.
Images were acquired with an Aperio’s ScanScope XT digital
scanning system.
Confocal Microscopy
Detection of vessel lumen was studied by confocal microscopy.
10 mmsections were immunostained with human-CD34 (clone
BQEND) and an anti-mouse Alexa FluorH 488 secondary
antibody. Images were acquired using a Leica TCS SP5 confocal
microscope and sequential Z-stacks were performed using a
6361.4NA oil immersion objective, zoom 3X, 0.3 mm Z step.
Acknowledgments
This manuscript is devoted to the late Cesare Peschle, deceased In June,
2011.
We thank Giuseppe Loreto for excellent graphical assistance, Agnese
D’Angio` for technical assistance, and Ercole Brunetti, A.Fa.R. Research
Centre San Pietro Hospital, Fatebenefratelli, Rome for cord blood supply.
We especially thank Patrizia Lavia and Giulia Guarguaglini (CNR Rome)
for their help in live imaging experiments and to Ms. Andrea Baker (INMI
Rome, Italy) for editing the manuscript.
Author Contributions
Conceived and designed the experiments: MT EP FB UT. Performed the
experiments: EP GC IMP VB SS AC AMC MSP PM MB TA LA MA.
Analyzed the data: MA. Wrote the paper: EP MT.
Cord Blood Derived Haemogenic Endothelium
PLOS ONE | www.plosone.org 11 December 2012 | Volume 7 | Issue 12 | e51109
References
1. Fehling HJ, Lacaud G, Kubo A, Kennedy M, Robertson S, et al. (2003)
Tracking mesoderm induction and its specification to the hemangioblast during
embryonic stem cell differentiation. Development 130: 4217–4227.
2. Kinder SJ, Tsang TE, Quinlan GA, Hadjantonakis AK, Nagy A, et al. (1999)
The orderly allocation of mesodermal cells to the extraembryonic structures and
the anteroposterior axis during gastrulation of the mouse embryo. Development
126: 4691–4701.
3. Robb L, Elefanty AG (1998) The hemangioblast–an elusive cell captured in
culture. Bioessays 20: 611–614.
4. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G (1998) A common
precursor for hematopoietic and endothelial cells. Development 125: 725–732.
5. Eichmann A, Corbel C, Nataf V, Vaigot P, Breant C, et al. (1997) Ligand-
dependent development of the endothelial and hemopoietic lineages from
embryonic mesodermal cells expressing vascular endothelial growth factor
receptor 2. Proc Natl Acad Sci U S A 94: 5141–5146.
6. Vogeli KM, Jin SW, Martin GR, Stainier DY (2006) A common progenitor for
haematopoietic and endothelial lineages in the zebrafish gastrula. Nature 443:
337–339.
7. Pelosi E, Valtieri M, Coppola S, Botta R, Gabbianelli M, et al. (2002)
Identification of the hemangioblast in postnatal life. Blood 100: 3203–3208.
8. Wu X, Lensch MW, Wylie-Sears J, Daley GQ, Bischoff J (2007) Hemogenic
endothelial progenitor cells isolated from human umbilical cord blood. Stem
Cells 25: 2770–2776.
9. Dieterlen-Lievre F, Jaffredo T (2009) Decoding the hemogenic endothelium in
mammals. Cell Stem Cell 4: 189–190.
10. Cumano A, Godin I (2007) Ontogeny of the hematopoietic system. Annu Rev
Immunol 25: 745–785.
11. Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, et al. (2008) Fate
tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell
3: 625–636.
12. Nishikawa SI, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H (1998)
Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-
cadherin+ cells at a diverging point of endothelial and hemopoietic lineages.
Development 125: 1747–1757.
13. Nishikawa SI, Nishikawa S, Kawamoto H, Yoshida H, Kizumoto M, et al.
(1998) In vitro generation of lymphohematopoietic cells from endothelial cells
purified from murine embryos. Immunity 8: 761–769.
14. Yokomizo T, Ogawa M, Osato M, Kanno T, Yoshida H, et al. (2001)
Requirement of Runx1/AML1/PEBP2alphaB for the generation of haemato-
poietic cells from endothelial cells. Genes Cells 6: 13–23.
15. Rhodes KE, Gekas C, Wang Y, Lux CT, Francis CS, et al. (2008) The
emergence of hematopoietic stem cells is initiated in the placental vasculature in
the absence of circulation. Cell Stem Cell 2: 252–263.
16. Eilken HM, Nishikawa S, Schroeder T (2009) Continuous single-cell imaging of
blood generation from haemogenic endothelium. Nature 457: 896–900.
17. Bertrand JY, Chi NC, Santoso B, Teng S, Stainier DY, et al. (2010)
Haematopoietic stem cells derive directly from aortic endothelium during
development. Nature 464: 108–111.
18. Kissa K, Herbomel P (2010) Blood stem cells emerge from aortic endothelium
by a novel type of cell transition. Nature 464: 112–115.
19. Boisset JC, van Cappellen W, Andrieu-Soler C, Galjart N, Dzierzak E, et al.
(2010) In vivo imaging of haematopoietic cells emerging from the mouse aortic
endothelium. Nature 464: 116–120.
20. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, et al. (2009) The
haemangioblast generates haematopoietic cells through a haemogenic endothe-
lium stage. Nature 457: 892–895.
21. Bordoni V, Alonzi T, Zanetta L, Khouri D, Conti A, et al. (2007) Hepatocyte-
conditioned medium sustains endothelial differentiation of human hematopoi-
etic-endothelial progenitors. Hepatology 45: 1218–1228.
22. Yoder MC (2009) Defining human endothelial progenitor cells. Journal of
thrombosis and haemostasis : JTH 7 Suppl 1: 49–52.
23. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA (2009) Runx1 is
required for the endothelial to haematopoietic cell transition but not thereafter.
Nature 457: 887–891.
24. Baker CD, Ryan SL, Ingram DA, Seedorf GJ, Abman SH, et al. (2009)
Endothelial colony-forming cells from preterm infants are increased and more
susceptible to hyperoxia. Am J Respir Crit Care Med 180: 454–461.
25. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, et al. (2004)
Identification of a novel hierarchy of endothelial progenitor cells using human
peripheral and umbilical cord blood. Blood 104: 2752–2760.
26. Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, et al. (2009)
Generation of induced pluripotent stem cells from human cord blood. Cell Stem
Cell 5: 434–441.
27. Choi JH, Ryu YS, Kim KH, Lee YR, Cha KW, et al. (2009) In vitro
development of a hemangioblast from a human embryonic stem cell,
SNUhES#3. Life Sci 85: 39–45.
28. Liu ZJ, Italiano J, Jr., Ferrer-Marin F, Gutti R, Bailey M, et al. (2011)
Developmental differences in megakaryocytopoiesis are associated with up-
regulated TPO signaling through mTOR and elevated GATA-1 levels in
neonatal megakaryocytes. Blood 117: 4106–4117.
29. Xiong JW (2008) Molecular and developmental biology of the hemangioblast.
Developmental dynamics : an official publication of the American Association of
Anatomists 237: 1218–1231.
30. Aiuti A, Cicchini C, Bernardini S, Fedele G, Amicone L, et al. (1998)
Hematopoietic support and cytokine expression of murine-stable hepatocyte cell
lines (MMH). Hepatology 28: 1645–1654.
31. Bordoni V, Alonzi T, Agrati C, Poccia F, Borsellino G, et al. (2004) Murine
hepatocyte cell lines promote expansion and differentiation of NK cells from
stem cell precursors. Hepatology 39: 1508–1516.
32. Maheshwari RK, Srikantan V, Bhartiya D, Kleinman HK, Grant DS (1991)
Differential effects of interferon gamma and alpha on in vitro model of
angiogenesis. J Cell Physiol 146: 164–169.
Cord Blood Derived Haemogenic Endothelium
PLOS ONE | www.plosone.org 12 December 2012 | Volume 7 | Issue 12 | e51109
